Glenmede Trust’s Nutanix NTNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-6,519
Closed -$386K 1439
2024
Q3
$386K Sell
6,519
-623
-9% -$34.2K ﹤0.01% 1016
2024
Q2
$406K Buy
7,142
+164
+2% +$10.1K ﹤0.01% 978
2024
Q1
$431K Sell
6,978
-221
-3% -$12.7K ﹤0.01% 965
2023
Q4
$343K Buy
+7,199
New +$291K ﹤0.01% 1003
2020
Q4
Sell
-28
Closed 1886
2020
Q3
$0 Buy
+28
New +$640 ﹤0.01% 2549
2018
Q3
Sell
-1,000
Closed -$52K 1694
2018
Q2
$52K Buy
+1,000
New +$55K ﹤0.01% 1428
2017
Q1
Sell
-1,035
Closed -$27K 2722
2016
Q4
$27K Buy
+1,035
New +$30.9K ﹤0.01% 1809

Other funds holding NTNX

Glenmede Trust's NTNX Position: Q4 2024 in Review

Glenmede Trust sold out of Nutanix (NTNX) in Q4 2024, closing a stake of 6,519 shares — an estimated $386K sold.

Glenmede Trust first reported a position in NTNX in Q4 2016 and held it in 7 quarters. The position peaked at $431K in Q1 2024. 510 funds tracked by Wall St. Rank hold NTNX as of Q4 2024.

  • Glenmede Trust reported no remaining Nutanix position as of Q4 2024 after selling out during the quarter.
  • Glenmede Trust sold 6,519 Nutanix shares in Q4 2024, an estimated $386K.
  • Glenmede Trust first reported a position in Nutanix in Q4 2016 and held it in 7 quarters.
  • Glenmede Trust's Nutanix position peaked at $431K in Q1 2024.
  • 510 funds tracked by Wall St. Rank held Nutanix as of Q4 2024.

Based on Glenmede Trust's 13F filing for Q4 2024, filed 14 Feb 2025.